Inventor · disambiguated record
Shaker A. Mousa
Also filed as: MOUSA SHAKER · MOUSA SHAKER A · MOUSA SHAKER AHMAD
14 granted patents·4 pending applications·95 citations·filing 2000–2023
91Inventor score
Files withMOUSA SHAKER A7SEHGAL LAKSHMAN R3BRISTOL MYERS SQUIBB PHARMA CO2UNIV TEMPLE2BIOVEC TRANSFUSION LLC1
Top patents by PatentIndex Score
18 records- 0193US7964338B2Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrierBIOVEC TRANSFUSION LLC·Filed 2006·Granted Jun 21, 2011·11 cites·7 claims
- 0292US8142992B2Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrierSEHGAL LAKSHMAN R·Filed 2009·Granted Mar 27, 2012·8 cites·19 claims
- 0391US8129103B2Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrierSEHGAL LAKSHMAN R·Filed 2008·Granted Mar 6, 2012·4 cites·18 claims
- 0491US8129104B2Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobinSEHGAL LAKSHMAN R·Filed 2009·Granted Mar 6, 2012·6 cites·18 claims
- 0591US6994852B1Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5BRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 7, 2006·23 cites·18 claims
- 0690US6346517B1Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 12, 2002·20 cites·16 claims
- 0784US8563053B2Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosisMOUSA SHAKER A·Filed 2010·Granted Oct 22, 2013·7 cites·22 claims
- 0882US6284726B1Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5UNIV TEMPLE·Filed 2000·Granted Sep 4, 2001·13 cites·25 claims
- 0974US10251842B1Nanocapsule containing a bioactive compound, and a method of reducing toxicity resulting from cancer therapyUNIV KING ABDULAZIZ·Filed 2017·Granted Apr 9, 2019·3 cites·18 claims
- 1066US2023414556A1Nano-hepatic targeted epigallocatechin gallate in dyslipidemiaMOUSA SHAKER A·Filed 2023·Application pending·0 cites
- 1165US2024376212A1Alpha v-integrin targeted small molecule drug conjugatesTARGETTHERA LLC·Filed 2023·Application pending·0 cites
- 1258US9572831B2Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasisMOUSA SHAKER A·Filed 2014·Granted Feb 21, 2017·0 cites·18 claims
- 1358US7332161B2Treatment of disease with antibodies against high molecular weight kininogen domain 5UNIV TEMPLE·Filed 2006·Granted Feb 19, 2008·0 cites·5 claims
- 1454US2002068719A1Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disordersFiled 2001·Application pending·0 cites
- 1551US9956181B2Composition of nanoformulated lycopene and method of using the compositionMOUSA SHAKER A·Filed 2016·Granted May 1, 2018·0 cites·15 claims
- 1641US9700042B2Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applicationsMOUSA SHAKER A·Filed 2015·Granted Jul 11, 2017·0 cites·8 claims
- 1740US9707318B2Compositions of novel bone patch in bone and vascular regenerationMOUSA SHAKER A·Filed 2010·Granted Jul 18, 2017·0 cites·7 claims
- 1839US2011104265A1Compositions and methods of targeted nanoformulations in the management of osteoporosisMOUSA SHAKER A·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shaker A. Mousa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →